IMDX vs META · rev $271.0K vs P/E 29, rev $60.80B
Insight Molecular Diagnostics Inc. (IMDX) versus Meta Platforms Inc. (META) — a side-by-side from cached financials, not a winner call.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Meta Platforms Inc. (META) is a internet content & information company listed on US. It is led by Mark Zuckerberg.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
Latest reported META revenue for 2026-06-30 was $60.80B. Net income was $15.85B. Revenue was up 8.0% from 2026-03-31 to 2026-06-30. META currently screens at market cap $1.64T and trailing P/E 28.8.
IMDX currently screens at market cap $0. META currently screens at market cap $1.64T and trailing P/E 28.8.
Not investment advice. Open the IMDX and META stock pages for the full models.
Not investment advice.